Marthe Minderman

发表

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma

M. Kersten, M. Spaargaren, S. Pals, 2020, Leukemia.

Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation

G. Adema, M. D. den Brok, S. Amigorena, 2016, Nature Communications.

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/ PD-L1/ PD-L2 alterations

A. Amir, P. Kluin, M. Spaargaren, 2021 .

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas

M. Kersten, R. Bende, C. V. van Noesel, 2023, Blood Cancer Journal.

Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma

S. Pals, Marthe Minderman, 2020, Haematologica.

Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma

S. Heegaard, P. Eriksen, S. Pals, 2021, British Journal of Ophthalmology.

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

C. von Buchwald, P. de Nully Brown, J. Vermaat, 2024, Blood advances.

Immune evasion in primary testicular and central nervous system lymphomas: HLA I and II loss rather than 9p24.1/PD-L1/PD-L2 alterations.

A. Amir, P. Kluin, M. Spaargaren, 2021, Blood.